Case reportClinical lung cancerPublished
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Case report
- Venue
- Clinical lung cancer
- Published
- Topic
- Clinical care
- Subject terms
- Drug resistance; Non-small cell lung cancer; Tyrosine kinase inhibitor; Egfr Mutation; Met Mutation
- PubMed ID
- 39743378
- Added to directory
- Source checked